Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 16 | 2006 | 774 | 1.140 |
Why?
|
Mercaptopurine | 6 | 2006 | 71 | 0.590 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 14 | 2006 | 1245 | 0.490 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 5 | 2001 | 129 | 0.470 |
Why?
|
Antimetabolites, Antineoplastic | 3 | 2006 | 185 | 0.430 |
Why?
|
Anemia, Iron-Deficiency | 2 | 2020 | 138 | 0.390 |
Why?
|
Methotrexate | 8 | 2005 | 336 | 0.390 |
Why?
|
Brain Neoplasms | 7 | 2008 | 1316 | 0.390 |
Why?
|
Neutropenia | 3 | 2000 | 196 | 0.310 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2008 | 42 | 0.300 |
Why?
|
Folic Acid Deficiency | 1 | 2008 | 53 | 0.300 |
Why?
|
Anemia, Sickle Cell | 3 | 2005 | 331 | 0.300 |
Why?
|
Radiotherapy, Conformal | 1 | 2008 | 55 | 0.290 |
Why?
|
Medulloblastoma | 4 | 2008 | 548 | 0.290 |
Why?
|
Child, Preschool | 38 | 2020 | 14152 | 0.290 |
Why?
|
Iron | 3 | 2020 | 276 | 0.270 |
Why?
|
Radiation Injuries | 1 | 2008 | 143 | 0.270 |
Why?
|
Meningeal Neoplasms | 2 | 2008 | 192 | 0.270 |
Why?
|
Carboplatin | 2 | 2000 | 77 | 0.270 |
Why?
|
Meningioma | 1 | 2008 | 118 | 0.260 |
Why?
|
Bone Marrow | 4 | 1998 | 323 | 0.250 |
Why?
|
Leukemia, Lymphoid | 7 | 1988 | 110 | 0.250 |
Why?
|
Hodgkin Disease | 3 | 1998 | 290 | 0.240 |
Why?
|
Salvage Therapy | 1 | 2006 | 185 | 0.230 |
Why?
|
Child | 41 | 2015 | 24610 | 0.210 |
Why?
|
Infant | 24 | 2020 | 12610 | 0.200 |
Why?
|
Chromosomes, Human, Pair 7 | 2 | 1996 | 74 | 0.200 |
Why?
|
Pulmonary Artery | 1 | 2005 | 437 | 0.190 |
Why?
|
Central Nervous System Diseases | 2 | 1998 | 108 | 0.190 |
Why?
|
Infusions, Intravenous | 5 | 2006 | 552 | 0.190 |
Why?
|
Myelodysplastic Syndromes | 2 | 1996 | 126 | 0.190 |
Why?
|
Administration, Oral | 6 | 2020 | 683 | 0.180 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2001 | 28 | 0.180 |
Why?
|
Male | 44 | 2020 | 61443 | 0.180 |
Why?
|
Hypertension, Pulmonary | 1 | 2005 | 439 | 0.180 |
Why?
|
Humans | 67 | 2020 | 125110 | 0.180 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2001 | 128 | 0.170 |
Why?
|
Optic Nerve Neoplasms | 1 | 2000 | 19 | 0.170 |
Why?
|
Antineoplastic Agents | 5 | 2000 | 1714 | 0.170 |
Why?
|
Splenectomy | 2 | 2012 | 62 | 0.170 |
Why?
|
Multi-Institutional Systems | 1 | 2000 | 12 | 0.170 |
Why?
|
Leukopenia | 1 | 2000 | 45 | 0.170 |
Why?
|
Nonprescription Drugs | 1 | 2000 | 47 | 0.160 |
Why?
|
Female | 41 | 2020 | 66704 | 0.160 |
Why?
|
Zinc | 1 | 2000 | 135 | 0.160 |
Why?
|
Adolescent | 27 | 2012 | 19414 | 0.160 |
Why?
|
Critical Pathways | 1 | 2000 | 79 | 0.160 |
Why?
|
Cytomegalovirus Infections | 1 | 2001 | 223 | 0.160 |
Why?
|
Program Development | 1 | 2000 | 182 | 0.150 |
Why?
|
Autoimmune Diseases | 1 | 2001 | 251 | 0.150 |
Why?
|
Thrombosis | 2 | 2015 | 520 | 0.150 |
Why?
|
Ventricular Function, Left | 1 | 2001 | 514 | 0.140 |
Why?
|
Glioma | 2 | 2000 | 513 | 0.140 |
Why?
|
Gene Amplification | 1 | 1998 | 236 | 0.140 |
Why?
|
Burkitt Lymphoma | 2 | 1998 | 144 | 0.130 |
Why?
|
Heart | 1 | 2001 | 731 | 0.130 |
Why?
|
Ganglioglioma | 1 | 1996 | 22 | 0.130 |
Why?
|
Isochromosomes | 1 | 1996 | 18 | 0.130 |
Why?
|
Anemia | 1 | 2000 | 341 | 0.130 |
Why?
|
Leukemia, Myelomonocytic, Juvenile | 1 | 2015 | 9 | 0.120 |
Why?
|
Remission Induction | 7 | 1998 | 292 | 0.120 |
Why?
|
Combined Modality Therapy | 7 | 2012 | 1237 | 0.120 |
Why?
|
Chromosome Aberrations | 2 | 1998 | 620 | 0.120 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 2 | 2012 | 49 | 0.120 |
Why?
|
Bone Marrow Transplantation | 2 | 1996 | 564 | 0.120 |
Why?
|
Antithrombin III | 1 | 2015 | 25 | 0.120 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2006 | 1155 | 0.120 |
Why?
|
Anemia, Hemolytic, Congenital Nonspherocytic | 1 | 1995 | 1 | 0.120 |
Why?
|
Pyruvate Kinase | 1 | 1995 | 9 | 0.120 |
Why?
|
Hospitals, Pediatric | 1 | 2000 | 768 | 0.120 |
Why?
|
Mediastinal Cyst | 1 | 1994 | 10 | 0.120 |
Why?
|
Mediastinal Diseases | 1 | 1994 | 14 | 0.120 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 1995 | 73 | 0.120 |
Why?
|
Disease-Free Survival | 4 | 2015 | 880 | 0.110 |
Why?
|
Bronchiolitis | 1 | 1995 | 122 | 0.110 |
Why?
|
Isoenzymes | 1 | 1995 | 232 | 0.110 |
Why?
|
Heparin | 1 | 2015 | 217 | 0.110 |
Why?
|
Parvovirus | 1 | 1993 | 8 | 0.110 |
Why?
|
Lymphocytes | 1 | 1995 | 408 | 0.110 |
Why?
|
Parvoviridae Infections | 1 | 1993 | 36 | 0.110 |
Why?
|
Panniculitis | 1 | 1993 | 19 | 0.110 |
Why?
|
Purpura | 1 | 1993 | 24 | 0.100 |
Why?
|
Abscess | 1 | 1994 | 139 | 0.100 |
Why?
|
Respiratory Syncytial Virus, Human | 1 | 1995 | 207 | 0.100 |
Why?
|
Hematoma | 1 | 1993 | 91 | 0.100 |
Why?
|
Diagnosis, Differential | 4 | 2008 | 1893 | 0.100 |
Why?
|
Haemophilus Vaccines | 1 | 1992 | 30 | 0.100 |
Why?
|
Organoplatinum Compounds | 1 | 1992 | 28 | 0.100 |
Why?
|
Acute Disease | 5 | 2015 | 1095 | 0.100 |
Why?
|
Tetanus Toxoid | 1 | 1992 | 45 | 0.100 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 1995 | 345 | 0.090 |
Why?
|
Bacterial Vaccines | 1 | 1992 | 99 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 9 | 2009 | 2093 | 0.090 |
Why?
|
Haemophilus Infections | 1 | 1992 | 91 | 0.090 |
Why?
|
Haemophilus influenzae | 1 | 1992 | 130 | 0.090 |
Why?
|
Mutation | 2 | 2015 | 5906 | 0.090 |
Why?
|
Proportional Hazards Models | 3 | 2000 | 1361 | 0.090 |
Why?
|
Splenic Infarction | 1 | 1991 | 4 | 0.090 |
Why?
|
Protein C Deficiency | 1 | 1991 | 12 | 0.090 |
Why?
|
Mesenteric Vascular Occlusion | 1 | 1991 | 28 | 0.090 |
Why?
|
Survival Rate | 5 | 2005 | 2051 | 0.090 |
Why?
|
Drug Administration Schedule | 4 | 2000 | 728 | 0.090 |
Why?
|
Anticoagulants | 1 | 2015 | 576 | 0.090 |
Why?
|
Thalassemia | 1 | 2010 | 11 | 0.080 |
Why?
|
Antibodies, Bacterial | 1 | 1992 | 390 | 0.080 |
Why?
|
Health Care Costs | 1 | 2012 | 371 | 0.080 |
Why?
|
Chlorambucil | 1 | 1989 | 6 | 0.080 |
Why?
|
Injections, Spinal | 4 | 1998 | 126 | 0.080 |
Why?
|
Purpura, Thrombocytopenic | 1 | 1988 | 7 | 0.080 |
Why?
|
gamma-Globulins | 1 | 1988 | 6 | 0.080 |
Why?
|
Leukemia, Myeloid, Acute | 4 | 1990 | 522 | 0.080 |
Why?
|
Vitamin B 12 | 1 | 2008 | 59 | 0.080 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 1989 | 96 | 0.080 |
Why?
|
Survival Analysis | 4 | 2000 | 1496 | 0.070 |
Why?
|
von Willebrand Diseases | 1 | 2009 | 51 | 0.070 |
Why?
|
Adult | 10 | 2020 | 29459 | 0.070 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2010 | 225 | 0.070 |
Why?
|
Genome-Wide Association Study | 1 | 2015 | 1694 | 0.070 |
Why?
|
Antidotes | 2 | 1998 | 14 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 5 | 2010 | 3600 | 0.070 |
Why?
|
Blood Cell Count | 2 | 2000 | 69 | 0.070 |
Why?
|
Bone Neoplasms | 2 | 1986 | 426 | 0.070 |
Why?
|
Leucovorin | 2 | 1998 | 49 | 0.070 |
Why?
|
Agranulocytosis | 1 | 1987 | 13 | 0.070 |
Why?
|
Glycogen Storage Disease Type I | 1 | 1987 | 11 | 0.070 |
Why?
|
Wilms Tumor | 1 | 2009 | 117 | 0.070 |
Why?
|
Lithium | 1 | 1987 | 67 | 0.070 |
Why?
|
Skin Diseases | 1 | 1989 | 129 | 0.070 |
Why?
|
Nutrition Surveys | 1 | 2008 | 295 | 0.070 |
Why?
|
Laparoscopy | 1 | 2012 | 491 | 0.070 |
Why?
|
Sex Factors | 4 | 2000 | 1275 | 0.070 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 1989 | 205 | 0.070 |
Why?
|
Karyotyping | 2 | 1998 | 323 | 0.070 |
Why?
|
Folic Acid | 1 | 2008 | 293 | 0.060 |
Why?
|
Staphylococcal Infections | 2 | 2006 | 561 | 0.060 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 1989 | 224 | 0.060 |
Why?
|
Chromosome Deletion | 1 | 1989 | 653 | 0.060 |
Why?
|
Polyglutamic Acid | 1 | 2005 | 3 | 0.060 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2005 | 112 | 0.060 |
Why?
|
Follow-Up Studies | 4 | 2005 | 5169 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 3175 | 0.060 |
Why?
|
Sensitivity and Specificity | 2 | 2010 | 2055 | 0.060 |
Why?
|
Prognosis | 5 | 2015 | 4683 | 0.060 |
Why?
|
Vincristine | 4 | 1995 | 191 | 0.060 |
Why?
|
Treatment Outcome | 6 | 2005 | 12272 | 0.060 |
Why?
|
Venous Thrombosis | 1 | 2006 | 167 | 0.060 |
Why?
|
Hearing Loss, High-Frequency | 1 | 1983 | 1 | 0.060 |
Why?
|
Myelin Basic Protein | 1 | 1984 | 68 | 0.050 |
Why?
|
Cohort Studies | 2 | 2005 | 4821 | 0.050 |
Why?
|
Osteomyelitis | 1 | 2006 | 205 | 0.050 |
Why?
|
Signal Transduction | 1 | 2015 | 4597 | 0.050 |
Why?
|
Algorithms | 1 | 2010 | 1630 | 0.050 |
Why?
|
Prednisone | 5 | 1995 | 278 | 0.050 |
Why?
|
Staphylococcus aureus | 1 | 2006 | 459 | 0.050 |
Why?
|
Hearing Loss | 1 | 1983 | 136 | 0.050 |
Why?
|
Leukocyte Count | 2 | 2000 | 251 | 0.050 |
Why?
|
Cisplatin | 1 | 1983 | 250 | 0.050 |
Why?
|
Prevalence | 1 | 2008 | 2458 | 0.050 |
Why?
|
Disease Progression | 2 | 2015 | 2084 | 0.050 |
Why?
|
Neoplasm Metastasis | 2 | 1981 | 705 | 0.050 |
Why?
|
Coombs Test | 1 | 2001 | 6 | 0.050 |
Why?
|
Cerebellar Neoplasms | 1 | 1986 | 443 | 0.050 |
Why?
|
Immune Sera | 1 | 2001 | 95 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2006 | 1114 | 0.050 |
Why?
|
Urine | 1 | 2001 | 82 | 0.050 |
Why?
|
Pilot Projects | 2 | 1996 | 1395 | 0.040 |
Why?
|
Methylprednisolone | 1 | 2001 | 93 | 0.040 |
Why?
|
Nasopharynx | 1 | 2001 | 80 | 0.040 |
Why?
|
Immunization, Passive | 1 | 2001 | 120 | 0.040 |
Why?
|
Monocytes | 1 | 1983 | 345 | 0.040 |
Why?
|
Self Medication | 1 | 2000 | 22 | 0.040 |
Why?
|
Acne Vulgaris | 1 | 2000 | 21 | 0.040 |
Why?
|
Oncology Nursing | 1 | 2000 | 10 | 0.040 |
Why?
|
Risk Factors | 2 | 2008 | 10278 | 0.040 |
Why?
|
Ploidies | 1 | 2000 | 37 | 0.040 |
Why?
|
Copper | 1 | 2000 | 63 | 0.040 |
Why?
|
Cytomegalovirus | 1 | 2001 | 269 | 0.040 |
Why?
|
Pediatric Nursing | 1 | 2000 | 25 | 0.040 |
Why?
|
Base Sequence | 2 | 1995 | 3109 | 0.040 |
Why?
|
Electroencephalography | 2 | 1981 | 869 | 0.040 |
Why?
|
Aspergillosis | 1 | 1979 | 43 | 0.040 |
Why?
|
Leukemia | 2 | 1990 | 367 | 0.040 |
Why?
|
Treatment Failure | 2 | 1998 | 335 | 0.040 |
Why?
|
Recurrence | 2 | 1993 | 1390 | 0.040 |
Why?
|
Chronic Disease | 3 | 2012 | 1187 | 0.040 |
Why?
|
Molecular Sequence Data | 2 | 1995 | 3898 | 0.040 |
Why?
|
Brain | 4 | 2001 | 3014 | 0.040 |
Why?
|
Cooperative Behavior | 1 | 2000 | 219 | 0.040 |
Why?
|
Neoplasms, Multiple Primary | 1 | 1979 | 71 | 0.040 |
Why?
|
Young Adult | 2 | 2010 | 9056 | 0.040 |
Why?
|
Immunoglobulin G | 1 | 2001 | 780 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 1982 | 420 | 0.040 |
Why?
|
B-Lymphocytes | 2 | 2005 | 532 | 0.040 |
Why?
|
Platelet Count | 3 | 2012 | 137 | 0.040 |
Why?
|
Injections, Intramuscular | 2 | 1995 | 194 | 0.040 |
Why?
|
Herpesviridae Infections | 2 | 1989 | 142 | 0.030 |
Why?
|
Neoplasms | 1 | 1992 | 2794 | 0.030 |
Why?
|
Hematopoietic Stem Cells | 2 | 2005 | 538 | 0.030 |
Why?
|
Disease Outbreaks | 1 | 1979 | 320 | 0.030 |
Why?
|
Patient Selection | 1 | 2000 | 694 | 0.030 |
Why?
|
Subarachnoid Space | 1 | 1996 | 24 | 0.030 |
Why?
|
Monosomy | 1 | 1996 | 24 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 1998 | 772 | 0.030 |
Why?
|
Melphalan | 1 | 1996 | 41 | 0.030 |
Why?
|
Echocardiography | 1 | 2001 | 1067 | 0.030 |
Why?
|
Osteosarcoma | 1 | 1979 | 255 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 1 | 1996 | 145 | 0.030 |
Why?
|
Germinoma | 1 | 1996 | 32 | 0.030 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1996 | 69 | 0.030 |
Why?
|
Patient Care Team | 1 | 2000 | 542 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 1996 | 272 | 0.030 |
Why?
|
Leukemia, Myeloid | 1 | 2015 | 81 | 0.030 |
Why?
|
Asparaginase | 1 | 1995 | 41 | 0.030 |
Why?
|
Partial Thromboplastin Time | 1 | 2015 | 47 | 0.030 |
Why?
|
DNA, Satellite | 1 | 1995 | 18 | 0.030 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 1995 | 70 | 0.030 |
Why?
|
Antithrombins | 1 | 2015 | 56 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 1996 | 366 | 0.030 |
Why?
|
Antibodies, Viral | 1 | 2001 | 1150 | 0.030 |
Why?
|
Factor Xa Inhibitors | 1 | 2015 | 64 | 0.030 |
Why?
|
United States | 2 | 2000 | 10884 | 0.030 |
Why?
|
Health Services Accessibility | 1 | 2020 | 605 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2012 | 16339 | 0.030 |
Why?
|
Staphylococcus | 1 | 1994 | 68 | 0.030 |
Why?
|
Ependymoma | 1 | 1996 | 164 | 0.030 |
Why?
|
Neoplasm Staging | 1 | 1998 | 1275 | 0.030 |
Why?
|
Blood Transfusion | 1 | 1996 | 312 | 0.030 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1995 | 369 | 0.030 |
Why?
|
Age Factors | 2 | 2000 | 2815 | 0.030 |
Why?
|
Cyclophosphamide | 1 | 1996 | 412 | 0.030 |
Why?
|
Prospective Studies | 2 | 2020 | 6123 | 0.030 |
Why?
|
Chromosome Mapping | 1 | 1996 | 1086 | 0.030 |
Why?
|
Haplotypes | 1 | 1995 | 520 | 0.030 |
Why?
|
Catheterization, Central Venous | 1 | 1994 | 128 | 0.030 |
Why?
|
Parents | 1 | 2020 | 1024 | 0.030 |
Why?
|
Leukemia, Myelomonocytic, Acute | 1 | 1992 | 7 | 0.030 |
Why?
|
Pons | 1 | 1993 | 33 | 0.030 |
Why?
|
Rho(D) Immune Globulin | 1 | 2012 | 8 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 2 | 2012 | 319 | 0.020 |
Why?
|
Demyelinating Diseases | 1 | 1993 | 64 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 1995 | 810 | 0.020 |
Why?
|
Pancytopenia | 1 | 1992 | 41 | 0.020 |
Why?
|
Bites and Stings | 1 | 2012 | 28 | 0.020 |
Why?
|
Central Nervous System Neoplasms | 1 | 1995 | 209 | 0.020 |
Why?
|
Pentosephosphates | 1 | 1992 | 9 | 0.020 |
Why?
|
Isoantibodies | 1 | 2012 | 72 | 0.020 |
Why?
|
Drug Evaluation | 1 | 1992 | 105 | 0.020 |
Why?
|
Drug Costs | 1 | 2012 | 61 | 0.020 |
Why?
|
Wound Infection | 1 | 2012 | 53 | 0.020 |
Why?
|
DNA, Viral | 1 | 1993 | 478 | 0.020 |
Why?
|
Immunologic Factors | 1 | 1993 | 173 | 0.020 |
Why?
|
Polysaccharides, Bacterial | 1 | 1992 | 68 | 0.020 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2012 | 145 | 0.020 |
Why?
|
Interferon-alpha | 1 | 1993 | 241 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 1995 | 819 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 1685 | 0.020 |
Why?
|
Dogs | 1 | 2012 | 772 | 0.020 |
Why?
|
Pedigree | 1 | 1995 | 1610 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 1995 | 1339 | 0.020 |
Why?
|
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 1 | 1990 | 2 | 0.020 |
Why?
|
Pyoderma | 1 | 1990 | 2 | 0.020 |
Why?
|
Deficiency Diseases | 1 | 1991 | 11 | 0.020 |
Why?
|
Hemiplegia | 1 | 1991 | 45 | 0.020 |
Why?
|
Hospital Costs | 1 | 2012 | 179 | 0.020 |
Why?
|
Ischemic Attack, Transient | 1 | 1991 | 56 | 0.020 |
Why?
|
Neutrophils | 1 | 1993 | 381 | 0.020 |
Why?
|
Neoplasms, Second Primary | 1 | 1992 | 146 | 0.020 |
Why?
|
Thrombocythemia, Essential | 1 | 1991 | 30 | 0.020 |
Why?
|
Mesenteric Arteries | 1 | 1991 | 56 | 0.020 |
Why?
|
Autoantibodies | 1 | 1993 | 433 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2015 | 963 | 0.020 |
Why?
|
Soft Tissue Neoplasms | 1 | 1992 | 122 | 0.020 |
Why?
|
Cecal Diseases | 1 | 1990 | 6 | 0.020 |
Why?
|
Immunocompromised Host | 1 | 2012 | 293 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 887 | 0.020 |
Why?
|
Bacteremia | 1 | 1994 | 400 | 0.020 |
Why?
|
Quinazolines | 1 | 1991 | 174 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 1993 | 1592 | 0.020 |
Why?
|
Sarcoma | 1 | 1992 | 184 | 0.020 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 1990 | 94 | 0.020 |
Why?
|
Middle Aged | 1 | 2008 | 26676 | 0.020 |
Why?
|
Herpesvirus 4, Human | 2 | 1989 | 674 | 0.020 |
Why?
|
Image Enhancement | 1 | 2010 | 163 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 1991 | 265 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2012 | 645 | 0.020 |
Why?
|
Necrosis | 2 | 1990 | 210 | 0.020 |
Why?
|
Anemia, Aplastic | 1 | 1988 | 57 | 0.020 |
Why?
|
Infant, Newborn | 4 | 2015 | 8275 | 0.020 |
Why?
|
Lithium Carbonate | 1 | 1987 | 21 | 0.020 |
Why?
|
Neoplasms, Muscle Tissue | 1 | 1987 | 10 | 0.020 |
Why?
|
Cells, Cultured | 1 | 1993 | 3044 | 0.020 |
Why?
|
Thigh | 1 | 1987 | 51 | 0.020 |
Why?
|
Ultrasonography | 2 | 1982 | 939 | 0.020 |
Why?
|
Kinetics | 1 | 2009 | 1330 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 1988 | 511 | 0.020 |
Why?
|
Methicillin Resistance | 1 | 2006 | 118 | 0.020 |
Why?
|
Bone Marrow Diseases | 1 | 1986 | 41 | 0.020 |
Why?
|
Brain Diseases | 1 | 1988 | 299 | 0.010 |
Why?
|
Bacterial Infections | 2 | 1990 | 304 | 0.010 |
Why?
|
Community-Acquired Infections | 1 | 2006 | 241 | 0.010 |
Why?
|
Pulmonary Embolism | 1 | 2006 | 174 | 0.010 |
Why?
|
Mechlorethamine | 2 | 1993 | 8 | 0.010 |
Why?
|
Procarbazine | 2 | 1993 | 12 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2010 | 2878 | 0.010 |
Why?
|
Seizures | 1 | 1988 | 868 | 0.010 |
Why?
|
Phagocytosis | 1 | 1983 | 171 | 0.010 |
Why?
|
Urography | 1 | 1981 | 30 | 0.010 |
Why?
|
Levamisole | 1 | 1981 | 4 | 0.010 |
Why?
|
Biomarkers | 1 | 2010 | 3105 | 0.010 |
Why?
|
Lymphocyte Transfusion | 1 | 1981 | 55 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2012 | 3047 | 0.010 |
Why?
|
BCG Vaccine | 1 | 1981 | 108 | 0.010 |
Why?
|
Air Movements | 1 | 1979 | 1 | 0.010 |
Why?
|
Maintenance and Engineering, Hospital | 1 | 1979 | 1 | 0.010 |
Why?
|
Air Conditioning | 1 | 1979 | 2 | 0.010 |
Why?
|
Air Microbiology | 1 | 1979 | 10 | 0.010 |
Why?
|
Testis | 1 | 1981 | 411 | 0.010 |
Why?
|
Technetium | 1 | 1979 | 12 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 1979 | 149 | 0.010 |
Why?
|
Neuroblastoma | 1 | 1983 | 529 | 0.010 |
Why?
|
Biopsy | 1 | 1981 | 1242 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 1998 | 307 | 0.010 |
Why?
|
Texas | 2 | 1992 | 3571 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 1981 | 635 | 0.010 |
Why?
|
Nervous System Diseases | 1 | 1981 | 373 | 0.010 |
Why?
|
Cross Infection | 1 | 1979 | 313 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 1981 | 1095 | 0.010 |
Why?
|
Kidney | 1 | 1981 | 1360 | 0.010 |
Why?
|
Coagulase | 1 | 1994 | 23 | 0.010 |
Why?
|
Electrophoresis | 1 | 1994 | 50 | 0.010 |
Why?
|
Liver | 1 | 1981 | 1748 | 0.010 |
Why?
|
Teniposide | 1 | 1993 | 2 | 0.010 |
Why?
|
Daunorubicin | 1 | 1993 | 27 | 0.010 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 1 | 1993 | 30 | 0.010 |
Why?
|
Cytarabine | 1 | 1993 | 96 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 1993 | 248 | 0.010 |
Why?
|
Vinblastine | 1 | 1993 | 55 | 0.010 |
Why?
|
Hydrocortisone | 1 | 1993 | 216 | 0.010 |
Why?
|
Dacarbazine | 1 | 1993 | 96 | 0.010 |
Why?
|
Bleomycin | 1 | 1993 | 153 | 0.010 |
Why?
|
Cranial Irradiation | 1 | 1992 | 69 | 0.010 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1993 | 235 | 0.010 |
Why?
|
Doxorubicin | 1 | 1993 | 288 | 0.010 |
Why?
|
Dysarthria | 1 | 1991 | 22 | 0.010 |
Why?
|
Animals | 1 | 2012 | 34304 | 0.010 |
Why?
|
Gangrene | 1 | 1990 | 26 | 0.010 |
Why?
|
Mumps | 1 | 1970 | 12 | 0.010 |
Why?
|
Environment, Controlled | 1 | 1990 | 8 | 0.010 |
Why?
|
Patient Isolation | 1 | 1990 | 14 | 0.010 |
Why?
|
Filtration | 1 | 1990 | 22 | 0.010 |
Why?
|
Whole-Body Irradiation | 1 | 1990 | 60 | 0.010 |
Why?
|
Autopsy | 1 | 1990 | 110 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 1993 | 1400 | 0.010 |
Why?
|
Aspirin | 1 | 1991 | 222 | 0.000 |
Why?
|
Immune Tolerance | 1 | 1990 | 144 | 0.000 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 1990 | 177 | 0.000 |
Why?
|
Population Surveillance | 1 | 1970 | 390 | 0.000 |
Why?
|
Sciatic Nerve | 1 | 1987 | 55 | 0.000 |
Why?
|
Frontal Lobe | 1 | 1988 | 116 | 0.000 |
Why?
|
Drug Therapy, Combination | 1 | 1991 | 1158 | 0.000 |
Why?
|
Graft vs Host Disease | 1 | 1990 | 503 | 0.000 |
Why?
|
Neoplasm Invasiveness | 1 | 1987 | 625 | 0.000 |
Why?
|
Inflammation | 1 | 1990 | 1447 | 0.000 |
Why?
|
Incidence | 1 | 1990 | 3131 | 0.000 |
Why?
|
Time Factors | 1 | 1988 | 6302 | 0.000 |
Why?
|
Florida | 1 | 1970 | 78 | 0.000 |
Why?
|
Hemagglutination Inhibition Tests | 1 | 1970 | 113 | 0.000 |
Why?
|
Serologic Tests | 1 | 1970 | 118 | 0.000 |
Why?
|